CureVac (NASDAQ:CVAC) | WebDisclosure

Basculer en Français

8695	Companies
150737	Keywords
86356	Articles
80885	Press releases

Home
Companies
CureVac

BRIEF

published on 05/20/2025 at 13:05, 13 days 8 hours ago

CureVac publie ses résultats financiers et ses développements commerciaux pour le premier trimestre 2025

Résultats Financiers Brevets Revenu Pipeline En Oncologie Développements En R&D
BRIEF

published on 05/20/2025 at 13:05, 13 days 8 hours ago

CureVac Reports Q1 2025 Financials and Business Developments

Financial Results Revenue Patents Oncology Pipeline R&D Developments
PRESS RELEASE

published on 05/20/2025 at 13:00, 13 days 8 hours ago

CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates
CureVac announces financial results for Q1 2025 and updates on lung cancer and glioblastoma trials, urinary tract infection vaccine, and mRNA patents. Cash position strong at €438.3 million

Financial Results Oncology Pipeline CureVac Q1 2025 MRNA Patents
BRIEF

published on 05/15/2025 at 22:15, 17 days 23 hours ago

CureVac obtient une décision favorable en matière de brevets contre BioNTech

BioNTech CureVac Technologie De L'ARNm Office Européen Des Brevets Litiges En Matière De Brevets
BRIEF

published on 05/15/2025 at 22:15, 17 days 23 hours ago

CureVac Gains Favorable Patent Decision Against BioNTech

BioNTech MRNA Technology CureVac Patent Litigation European Patent Office
PRESS RELEASE

published on 05/15/2025 at 22:10, 17 days 23 hours ago

CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE
CureVac receives positive validity decision on European patent against BioNTech SE in ongoing litigation, marking second EPO ruling in favor of CureVac

Patent BioNTech SE Litigation CureVac European Patent Office
BRIEF

published on 04/10/2025 at 13:17, 1 month 22 days ago

CureVac's 2024 Financial Results and Strategic Developments

Financial Results MRNA Technology Patent Litigation GSK Collaboration Oncology Programs
BRIEF

published on 04/10/2025 at 13:17, 1 month 22 days ago

Résultats financiers et développements stratégiques de CureVac pour 2024

Résultats Financiers Technologie De L'ARNm Collaboration GSK Litiges En Matière De Brevets Programmes D'oncologie
PRESS RELEASE

published on 04/10/2025 at 13:12, 1 month 22 days ago

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update
CureVac announces financial results for the fourth quarter and full-year 2024 and provides a business update, including milestone achievements, financial discipline, and litigation updates

Financial Results Business Update Intellectual Property CureVac Precision Immunotherapy
BRIEF

published on 04/08/2025 at 13:05, 1 month 24 days ago

CureVac Announces Financial Results and Business Update for 2024

Financial Results Conference Call Business Update MRNA Technology CureVac

Accesswire

Published on 06/02/2025 at 15:00, 6 hours 45 minutes ago

Newsmax to Participate in Maxim Group's "2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow" Virtual Conference
Published on 06/02/2025 at 15:00, 6 hours 45 minutes ago

1933 Industries Announces the Completion of the Purchase of 9% Interest of Cultivation and Production Subsidiary
Published on 06/02/2025 at 14:55, 6 hours 50 minutes ago

Tectonic Metals Launches Largest Drill Program to Date with Three Drill Rigs at Flat Gold Project, Alaska
Published on 06/02/2025 at 14:35, 7 hours 10 minutes ago

Sekur Private Data Ltd. Announces Newly Constituted Strategic Advisory Board - Appoints Jill Kelley as Chair of the Board
Published on 06/02/2025 at 14:30, 7 hours 15 minutes ago

Appointment of Nicholas Holthouse as President & CEO

View all ACCESSWIRE

EQS Group

Published on 06/02/2025 at 20:11, 1 hour 34 minutes ago

Shareholders of flatexDEGIRO AG elect new Supervisory Board and approve dividend of 4 cents per share
Published on 06/02/2025 at 19:24, 2 hours 20 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/02/2025 at 19:16, 2 hours 29 minutes ago

Elbe BidCo AG submits specified demand for squeeze-out and determines cash settlement for transfer of the shares of the minority shareholders of ENCAVIS AG at EUR 17.23
Published on 06/02/2025 at 19:00, 2 hours 45 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 26 MAI 2025 au 30 MAI 2025
Published on 06/02/2025 at 19:00, 2 hours 45 minutes ago

PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF

Les Echos

Published on 06/02/2025 at 18:43, 3 hours 2 minutes ago

Monthly disclosure of the total number of shares and voting rights - May 2025
Published on 06/02/2025 at 18:43, 3 hours 2 minutes ago

Déclaration mensuelle des actions et droits de vote – Mai 2025
Published on 06/02/2025 at 18:20, 3 hours 25 minutes ago

Reporting on share buyback transactions carried out between May 22 and May 23, 2025
Published on 06/02/2025 at 18:20, 3 hours 25 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 22 et 23 mai 2025
Published on 06/02/2025 at 18:00, 3 hours 45 minutes ago

Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social

View all LES ECHOS COMFI WIRE